News

Home > Viva BioInnovator (VBI) Successfully Held Demo Day 2

Viva BioInnovator (VBI) Successfully Held Demo Day 2

Publication time: 2020-09-18 Article source: Shanghai

demo day 2.png


On September 10, 2020, Viva BioInnovator (VBI) successfully held Demo Day 2. Among nearly 60 incubation portfolio companies from the VBI platform, 5 startup companies attended this event, namely AmacaThera, XLEMENT, Path Therapeutics, Reglagene and VivaVision, covering numerous fields including pain, biochip detection, intractable epilepsy, eye diseases and cancer.

demo day 2-1.png


demo day 2-2.png


demo day 2-3.png


demo day 2-4.png


demo day 2-5.png


Over 200 domestic and overseas top-tier investors, representatives of investment institutions, R&D representatives of pharmaceutical companies, etc. participated in the event and conducted in-depth communication with company founders in an interactive way online.